About 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one
2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one (PubChem CID 69087816) has the molecular formula C28H38N8O3
and a molecular weight of 534.67 g/mol. Its IUPAC name is 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one.
Molecular Properties
| Compound Name | 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one |
| PubChem CID | 69087816 |
| Molecular Formula | C28H38N8O3 |
| Molecular Weight | 534.67 g/mol |
| Exact Mass | 534.31 |
| IUPAC Name | 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one |
| SMILES | CC(C)C1=NC2C=CC=CC2N1c1nc(N2CCOCC2)c2nc(CC3CN(C(=O)C(C)(C)O)C3)n(C)c2n1 |
| InChI | InChI=1S/C28H38N8O3/c1-17(2)23-29-19-8-6-7-9-20(19)36(23)27-31-24-22(25(32-27)34-10-12-39-13-11-34)30-21(33(24)5)14-18-15-35(16-18)26(37)28(3,4)38/h6-9,17-20,38H,10-16H2,1-5H3 |
| InChIKey | IHTVQDSSRIKCGS-UHFFFAOYSA-N |
| XLogP | 1.71 |
| TPSA | 112.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 534.67 |
| LogP ≤ 5 | 1.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Analyze 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one?
The IUPAC name of 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one (CID 69087816) is 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one.
What is the SMILES notation for 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one?
The canonical SMILES for 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one is CC(C)C1=NC2C=CC=CC2N1c1nc(N2CCOCC2)c2nc(CC3CN(C(=O)C(C)(C)O)C3)n(C)c2n1.
What is the InChIKey of 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one?
The InChIKey is IHTVQDSSRIKCGS-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H38N8O3/c1-17(2)23-29-19-8-6-7-9-20(19)36(23)27-31-24-22(25(32-27)34-10-12-39-13-11-34)30-21(33(24)5)14-18-15-35(16-18)26(37)28(3,4)38/h6-9,17-20,38H,10-16H2,1-5H3.
What are the key properties of 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one?
2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one has a molecular weight of 534.67 g/mol, XLogP of 1.71, 6 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-hydroxy-2-methyl-1-[3-[[9-methyl-6-morpholin-4-yl-2-(2-propan-2-yl-3a,7a-dihydrobenzimidazol-1-yl)purin-8-yl]methyl]azetidin-1-yl]propan-1-one is sourced from PubChem (CID 69087816), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).